For information on our TSX listing, please visit https://web.tmxmoney.com/quote.php?locale=en&qm_symbol=ONC
For information on our OTCQX listing, please visit https://www.otcmarkets.com/stock/ONCYF/quote
Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas
Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer
Oncolytics Biotech® to Present at the Oncolytic Virotherapy Summit
View All NewsOncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More
Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More
Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More
Data from a Mayo study show pelareorep demonstrated the potential to broaden the applicability of CAR T cells to so… https://t.co/ausWexcm4f
Learn how pelareorep works with immunotherapies in this brief clip, a full length version of this video can be foun… https://t.co/UqCHYemBKi